Study of JYB1904 for chronic spontaneous urticaria
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial tests a new injectable medicine (JYB1904) to see if it can reduce itching and hives better than standard antihistamines alone. If you have chronic hives with no clear cause and still get symptoms despite taking antihistamines, this study may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been diagnosed with chronic spontaneous urticaria (hives with no clear cause) for at least 6 months.
- You have had itching and hives for at least 6 weeks in a row at some point before screening.
- You are currently taking a stable dose of a second-generation antihistamine (like cetirizine or loratadine) for at least 6 weeks.
- Your hives are not triggered by things like pressure, cold, heat, water, or exercise.
- You do not have other skin conditions that cause itching (like eczema or psoriasis) or a history of severe allergic shock.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, JYB1904, for people with chronic hives (itching and welts) that haven't been controlled by standard allergy pills. It aims to see if JYB1904 can reduce itching and hives better.
This trial tests a new oral medication called tacabrutideg (BGB-16673) for chronic spontaneous urticaria, a condition with frequent hives and itching. It aims to see how safe it is and how well it works, possibly offering a new option for people who still have symptoms despite antihistamines.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This study tests a new medication called HRS-3095 to see if it can help people whose chronic hives (itchy welts) do not get better with standard allergy pills. It aims to reduce itching and wheals and improve quality of life.
This study tests an experimental capsule (HS-10561) to see if it is safe and works for people with chronic spontaneous urticaria, which causes hives and itching without a clear trigger. If you have had hives for at least 6 months, you might be able to join.
This study tests a new investigational drug called AK139 to see if it can reduce the itching and hives caused by chronic spontaneous urticaria (also known as chronic hives). It may offer a new treatment option for people whose hives are not well controlled with antihistamines.
Hear when a new Chronic Spontaneous Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.